David Shaw’s BioLife Solutions BLFS Stock Holding History

David Shaw’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$349K	Sell	12,349 -89,521	-88%	-$2.09M	﹤0.01%	4347
2026 Q1	$1.94M	Sell	101,870 -64,511	-39%	-$1.43M	﹤0.01%	2939
2025 Q4	$4.02M	Sell	166,381 -119,162	-42%	-$3.12M	﹤0.01%	2490
2025 Q3	$7.28M	Buy	285,543 +169,831	+147%	+$4.03M	﹤0.01%	1906
2025 Q2	$2.49M	Buy	+115,712	New	+$2.61M	﹤0.01%	2579
2021 Q2	–	Sell	-47,657	Closed	-$1.72M	–	4753
2021 Q1	$1.72M	Sell	47,657 -72,194	-60%	-$2.85M	﹤0.01%	2717
2020 Q4	$4.78M	Buy	119,851 +77,467	+183%	+$2.64M	﹤0.01%	1913
2020 Q3	$1.23M	Buy	+42,384	New	+$915K	﹤0.01%	2730

Other funds holding BLFS

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

David Shaw's BLFS Position: Q2 2026 in Review

David Shaw reduced its BioLife Solutions (BLFS) stake by 88% in Q2 2026, selling an estimated $2.09M and leaving 12,349 shares worth $349K. The position accounts for ﹤0.01% of the portfolio, ranked #4347.

David Shaw first reported a position in BLFS in Q3 2020 and has held it in 8 quarters since. The position peaked at $7.28M in Q3 2025. 215 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

David Shaw held 12,349 shares of BioLife Solutions worth $349K as of Q2 2026.
David Shaw sold 89,521 BioLife Solutions shares in Q2 2026, an estimated $2.09M.
BioLife Solutions made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #4347 holding.
David Shaw first reported a position in BioLife Solutions in Q3 2020 and has held it in 8 quarters since.
David Shaw's BioLife Solutions position peaked at $7.28M in Q3 2025.
215 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.